Mórocz István. Focal nodular hyperplasia of the liver after clomiphene treatment in a young boy. (1986) ACTA PAEDIATRICA HUNGARICA 0231-441X 27 1 p. 15-21,
2382032
Al-AmoudiWael M. Biochemical and Histological Effects of Clomiphene Citrate on Liver of Female Albino Rat. (2012) JOURNAL OF AMERICAN SCIENCE 1545-1003 8 5 p. 1
Wolf R et al. Focal nodular hyperplasia of the liver after intraconazole treatment. (2001) JOURNAL OF CLINICAL GASTROENTEROLOGY 0192-0790 1539-2031 33 5 418-420
ReymondDidier et al. Focal nodular hyperplasia of the liver in childhood. (1993) MEDICAL AND PEDIATRIC ONCOLOGY 0098-1532 1096-911X 1545-5017 21 4 283-286
Benko I et al. Comparison of the toxicity of fluconazole and other azole antifungal drugs to murine and human granulocyte-macrophage progenitor cells in vitro. (1999) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY 0305-7453 1460-2091 43 675-681,
112595
Lee J.-H. et al. Second-phase validation study of an alternative developmental toxicity test using mouse embryonic stem cell-derived embryoid bodies. (2020) JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 0867-5910 1899-1505 71 2 1-11
Ptaszynska Natalia et al. Peptide conjugates of lactoferricin analogues and antimicrobials-Design, chemical synthesis, and evaluation of antimicrobial activity and mammalian cytotoxicity. (2019) PEPTIDES 0196-9781 1873-5169 117
Ng Siew Mei et al. Structure-activity relationship studies of ultra-short peptides with potent activities against fluconazole-resistant Candida albicans. (2018) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 0223-5234 1768-3254 150 479-490
Saha Himadri et al. Effects of fluconazole based medicated feed on haemato-immunological responses and resistance of Labeo rohita against Saprolegnia parasitica. (2017) FISH AND SHELLFISH IMMUNOLOGY 1050-4648 1095-9947 71 346-352
Brengel Christian et al. Biophysical Screening of a Focused Library for the Discovery of CYP121 Inhibitors as Novel Antimycobacterials. (2017) CHEMMEDCHEM 1860-7179 1860-7187 12 19 1616-1626
Xue Peng et al. Antifungal activity and mechanism of heat-transformed ginsenosides from notoginseng against Epidermophyton floccosum, Trichophyton rubrum, and Trichophyton mentagrophytes. (2017) RSC ADVANCES 2046-2069 7 18 10939-10946
Shin Y K et al. Macelignan inhibits bee pathogenic fungi Ascophaera apis growth through HOG1 pathway. (2016) BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH 0100-879X 1414-431X 49 7
Suloglu Aysun et al. In vivo toxicity of a new antifungal agent 2,4-dithiophenoxy-1-iodo-4-bromo benzene: a follow up on our in vitro study. (2015) ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU / ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY 0004-1254 1848-6312 66 1 63-72
Houël E et al. In vitro antidermatophytic activity of Otacanthus azureus (Linden) Ronse essential oil alone and in combination with azoles. (2014) JOURNAL OF APPLIED MICROBIOLOGY 1364-5072 1365-2672 116 2 288-294
Cabral ME et al. Synergistic antifungal activity of statin-azole associations as witnessed by Saccharomyces cerevisiae- and Candida utilis-bioassays and ergosterol quantification. (2013) REVISTA IBEROAMERICANA DE MICOLOGIA 1130-1406 30 1 31-38
Dovigo LN et al. Susceptibility of clinical isolates of Candida to photodynamic effects of curcumin. (2011) LASERS IN SURGERY AND MEDICINE 0196-8092 1096-9101 43 9 927-934
Dovigo LN et al. Investigation of the Photodynamic Effects of Curcumin Against Candida albicans. (2011) PHOTOCHEMISTRY AND PHOTOBIOLOGY 0031-8655 1751-1097 87 4 895-903
Dover LG et al. New drugs and vaccines for drug-resistant Mycobacterium tuberculosis infections. (2008) EXPERT REVIEW OF VACCINES 1476-0584 1744-8395 7 4 481-497
Riedl M et al. Long term control of hypercortisolism with fluconazole: case report and in vitro studies. (2006) EUROPEAN JOURNAL OF ENDOCRINOLOGY 0804-4643 1479-683X 154 4 519-524
Ahmad Z et al. In vitro and ex vivo antimycobacterial potential of azole drugs against Mycobacterium tuberculosis H(37)Rv. (2005) FEMS MICROBIOLOGY LETTERS 0378-1097 251 1 19-22
Chang HT et al. Effect of miconazole on intracellular Ca2+ levels and proliferation in human osteosarcoma cells. (2005) LIFE SCIENCES 0024-3205 76 18 2091-2101
Gal Z et al. A synthetic gamma-lactone group with beta-lactamase inhibitory and sporulation initiation effects. (2000) JOURNAL OF CHEMOTHERAPY 1120-009X 1973-9478 12 4 274-279
Benkő I et al. Effect of myelopoietic and pleiotropic cytokines on colony formation of blast cells of children with acute lymphoblastic leukemia. (2000) MEDICAL AND PEDIATRIC ONCOLOGY 0098-1532 1096-911X 1545-5017 35 3 p. 226,
1244201
Chang Hung et al. Clinical and Laboratory Significance of Defective P2Y(12) Pathway Function in Patients with Myeloproliferative Neoplasms: A Pilot Study. (2013) ACTA HAEMATOLOGICA 0001-5792 1421-9662 130 3 181-187
Tefferi Ayalew. Leukocytosis as a risk factor for thrombosis in myeloproliferative neoplasms-biologically plausible but clinically uncertain. (2010) AMERICAN JOURNAL OF HEMATOLOGY 0361-8609 1096-8652 85 2 93-94
Loesche Wolfgang et al. Value of platelet activation markers as prothrombotic risk indicators. (2007) TRANSFUSION MEDICINE AND HEMOTHERAPY 1660-3796 34 1 34-42
Cleanthis M et al. Platelet monocyte aggregates and monocyte chemoattractant protein-1 are not inhibited by aspirin in critical limb ischaemia. (2007) EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY 1078-5884 1532-2165 33 6 725-730
Sasse EC et al. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia. (2005) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 3
Gal Zs et al. A synthetic γ-lactone group with β-lactamase inhibitory and sporulation initiation effects. (2000) JOURNAL OF CHEMOTHERAPY 1120-009X 1973-9478 12 4 274-279,
2389079
Benko I et al. Effect of myelopoietic and pleiotropic cytokines on colony formation by blast cells of children with acute lymphoblastic leukemia. (2001) NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY 0028-1298 1432-1912 363 5 499-508,
1192592
Márkász László. In vitro gyógyszerérzékenységi vizsgálat az individualizált daganatellenes kemoterápiában: In Vitro Drug Sensitivity Test in the Individualized Anti-Cancer Chemotherapy. (2007)
Sasse EC et al. Colony stimulating factors for prevention of myelosupressive therapy induced febrile neutropenia in children with acute lymphoblastic leukaemia.. (2005) COCHRANE DATABASE OF SYSTEMATIC REVIEWS 1469-493X 3 art.no. CD004139-pub2
Benko I et al. Rosiglitazone-induced protection against myelotoxicity produced by 5-fluorouracil. (2003) EUROPEAN JOURNAL OF PHARMACOLOGY 0014-2999 1879-0712 477 2 179-182,
1311568
Ahmed A A et al. Antidepressant-like effects of rosiglitazone, a PPAR gamma agonist, in the rat forced swim and mouse tail suspension tests. (2009) BEHAVIOURAL PHARMACOLOGY 0955-8810 1473-5849 20 7 635-642
Girnun G D et al. Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin. (2008) CLINICAL CANCER RESEARCH 1078-0432 1557-3265 14 20 p. 6478-6486
Digman Colleen et al. Leukopenia and thrombocytopenia caused by thiazolidinediones. (2005) ANNALS OF INTERNAL MEDICINE 0003-4819 1539-3704 143 6 465-466
Agarwal A et al. Functional RNAi screen targeting cytokine and growth factor receptors reveals oncorequisite role for interleukin-2 gamma receptor in JAK3-mutation-positive leukemia. (2015) ONCOGENE 0950-9232 1476-5594 34 23 2991-2999
Lambrou GI et al. Pathway simulations in common oncogenic drivers of leukemic and rhabdomyosarcoma cells: A systems biology approach. (2012) INTERNATIONAL JOURNAL OF ONCOLOGY 1019-6439 1791-2423 40 5 1365-1390
Fredly H et al. Disease-stabilizing treatment with all-trans retinoic acid and valproic acid in acute myeloid leukemia: Serum hsp70 and hsp90 levels and serum cytokine profiles are determined by the disease, patient age, and anti-leukemic treatment. (2012) AMERICAN JOURNAL OF HEMATOLOGY 0361-8609 1096-8652 87 4 368-376
Tajima N et al. JTE-607, a multiple cytokine production inhibitor, induces apoptosis accompanied by an increase in p21waf1/cip1 in acute myelogenous leukemia cells. (2010) CANCER SCIENCE: THE OFFICIAL JOURNAL OF THE JAPANESE CANCER ASSOCIATION 1347-9032 1349-7006 101 3 774-781
Avramis IA et al. Correlation between high vascular endothelial growth factor-A serum levels and treatment outcome in patients with standard-risk acute lymphoblastic leukemia: A report from Children's Oncology Group Study CCG-1962. (2006) CLINICAL CANCER RESEARCH 1078-0432 1557-3265 12 23 6978-6984
Gyulai Z et al. Genetic polymorphisms in patients with myelodysplastic syndrome. (2005) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 52 463-475
Leung K et al. Cytokines in the differentiation therapy of leukemia: From laboratory investigations to clinical applications. (2005) CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES 1040-8363 1549-781X 42 473-514
Balog A et al. Clinical importance of transforming growth factor-beta but not of tumor necrosis factor-alpha gene polymorphisms in patients with the myelodysplastic syndrome belonging to the refractory anemia subtype. (2005) PATHOBIOLOGY 1015-2008 1423-0291 72 3 165-170
Djazayeri K et al. Accelerated recovery of 5-fluorouracil-damaged bone marrow after rosiglitazone treatment. (2005) EUROPEAN JOURNAL OF PHARMACOLOGY 0014-2999 1879-0712 522 1-3 122-129,
1033994
Tedesco Serena et al. Pharmacologic PPAR-gamma Activation Reprograms Bone Marrow Macrophages and Partially Rescues HSPC Mobilization in Human and Murine Diabetes. (2020) DIABETES 0012-1797 1939-327X 69 7 1562-1572
Sarkar Chandrani et al. Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia. (2015) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 137 3 744-749
Carvalho AA. 5-Fluorouracil and its immunotoxicity: A clinical and experimental approach. (2012) Megjelent: Fluorouracil: Synthesis, Health Effects and Role in Chemotherapy pp. 65-82
Richard CL et al. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner. (2007) INTERNATIONAL JOURNAL OF ONCOLOGY 1019-6439 1791-2423 30 5 1215-1222
Hou S et al. Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU. (2007) CANCER IMMUNOLOGY IMMUNOTHERAPY 1432-0851 0340-7004 56 10 1605-1613
Richard CL et al. 15-Deoxy-Delta(12,14)-prostaglandin J(2) down-regulates CXCR4 on carcinoma cells through PPAR gamma- and NF kappa B-mediated pathways. (2007) EXPERIMENTAL CELL RESEARCH 0014-4827 1090-2422 313 16 3446-3458
Gu CH et al. Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells. (2006) LEUKEMIA RESEARCH 0145-2126 1873-5835 30 11 1447-1451
SieradzkiJacek et al. Ocena bezpieczeństwa i skuteczności stosowania preparatu AVANDIA (rosiglitazon) w leczeniu cukrzycy typu 2-program ROSE. (2006) DIABETOLOGIA KLINICZNA 2084-4441 2299-2529 7 1 1-7
Aviñó A et al. Thrombin Binding Aptamer, more than a Simple Aptamer: Chemically Modified Derivatives and Biomedical Applications. (2012) CURRENT PHARMACEUTICAL DESIGN 1381-6128 1873-4286 18 14 2036-2047
Kanizsai Sz. et al. Antiretroviral effect of 4-thio-uridylate agains human immunodeficiency virus type 1. (2012) ACTA MICROBIOLOGICA ET IMMUNOLOGICA HUNGARICA 1217-8950 1588-2640 59 4 499-510
Jekle A et al. CD4-BFFI: A novel, bifunctional HIV-1 entry inhibitor with high and broad antiviral potency. (2009) ANTIVIRAL RESEARCH 0166-3542 83 3 257-266
Luganini A et al. Phosphorothioate-modified oligodeoxynucleotides inhibit human cytomegalovirus replication by blocking virus entry. (2008) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 0066-4804 1098-6596 52 3 1111-1120
NaumenkoV A. Application of confocal microscopy to the use of a study of the morphogenesis of human immunodeficiency virus type 1. (2008) VOPROSY VIRUSOLOGII 0507-4088 53 3 4-8
Ambrus JL et al. Treatment of viral and neoplastic diseases with double-stranded RNA derivatives and other new agents. (2006) EXPERIMENTAL BIOLOGY AND MEDICINE 1535-3702 1535-3699 231 8 1283-1286
Keseru JS et al. Investigation of beta-lactamases in clinical isolates of Staphylococcus aureus for further explanation of borderline methicillin resistance. (2005) CHEMOTHERAPY 0009-3157 1421-9794 51 6 300-304,
2269936
Zhu Yingdi et al. Detection of antimicrobial resistance-associated proteins by titanium dioxide-facilitated intact bacteria mass spectrometry. (2018) CHEMICAL SCIENCE 2041-6520 2041-6539 9 8 2212-2221
Hryniewicz Maria M et al. Borderline oxacillin-resistant Staphylococcus aureus (BORSA) - a more common problem than expected?. (2017) JOURNAL OF MEDICAL MICROBIOLOGY 0022-2615 66 10 1367-1373
Metwally L et al. Detection of methicillin-resistant Staphylococcus aureus directly by loop-mediated isothermal amplification and direct cefoxitin disk diffusion tests. (2014) EASTERN MEDITERRANEAN HEALTH JOURNAL 1020-3397 1687-1634 20 4 273-279
Ferreira AM et al. Oxacillin resistance and antimicrobial susceptibility profile of staphylococcussaprophyticus and other staphylococci isolated from patients with urinary tract infection. (2012) CHEMOTHERAPY 0009-3157 1421-9794 58 6 482-491
LimSu-Ho. Analysis of Inpatients with Bacterial Keratitis Over a 12-Year Period: Pathogenic Organisms and Antibiotic Resistance. (2012) JOURNAL OF THE KOREAN OPHTHALMOLOGICAL SOCIETY 0378-6471 2092-9374 53 3 372-384
Martins Andre et al. Oxacillin Resistance of Staphylococcus aureus Isolated from the University Hospital of Botucatu Medical School in Brazil. (2010) CHEMOTHERAPY 0009-3157 1421-9794 56 2 112-119
Wu Dejing et al. Epidemiology and molecular characteristics of community-associated methicillin-resistant and methicillin-susceptible Staphylococcus aureus from skin/soft tissue infections in a children's hospital in Beijing, China. (2010) DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE 0732-8893 1879-0070 67 1 1-8
Croes S et al. Diminished in vitro antibacterial activity of oxacillin against clinical isolates of borderline oxacillin-resistant Staphylococcus aureus. (2010) CLINICAL MICROBIOLOGY AND INFECTION 1198-743X 1469-0691 16 7 979-985
Donker G A et al. The population structure of Staphylococcus aureus among general practice patients from The Netherlands. (2009) CLINICAL MICROBIOLOGY AND INFECTION 1198-743X 1469-0691 15 2 137-143
Skinner Stuart et al. Failure of Cloxacillin in Treatment of a Patient with Borderline Oxacillin-Resistant Staphylococcus aureus Endocarditis. (2009) JOURNAL OF CLINICAL MICROBIOLOGY 0095-1137 1098-660X 47 3 859-861
Donker G et al. Prevalence of antibiotic-resistant S.aureus among general practice patients. (2006) EUROPEAN JOURNAL OF PUBLIC HEALTH 1101-1262 1464-360X 16 186-186
Nadarajah Jeya et al. Identification of different clonal complexes and diverse amino acid substitutions in penicillin-binding protein 2 (PBP2) associated with borderline oxacillin resistance in Canadian Staphylococcus aureus isolates. (2006) JOURNAL OF MEDICAL MICROBIOLOGY 0022-2615 55 12 1675-1683
Djazayeri K et al. Effect of rosiglitazone, an insulin sensitizer, on myelotoxicity caused by repeated doses of 5-fluorouracil. (2006) PHARMACOLOGICAL RESEARCH 1043-6618 1096-1186 53 2 156-161,
1373773
Tong CY (Tong Chunyi et al. Preparation of Micro-spheres Co-carried Anti-tumor Drug and Sensitizer (5-Fu-COS/SeNP) and Their Inhibiting Tumorous Cellular Growths Activity. (2014) CHEMICAL JOURNAL OF CHINESE UNIVERSITIES-CHINESE 0251-0790 35 7 1603-1607
Aljanabi SM. Accelerated Recovery of 5-Fluorouracil-Damaged Bone Marrow after Oxytocin Treatment. (2013) RESEARCH JOURNAL OF PHARMACY AND TECHNOLOGY 0974-3618 0974-360X 6 6 685-687
Aljanabi SM. Accelerated recovery of 5-fluorouracil-damaged bone marrow after oxytocin treatment. (2013) INTERNATIONAL JOURNAL OF PHARMA AND BIO SCIENCES 0975-6299 4 3 P223-P227
Girnun G D et al. Regression of Drug-Resistant Lung Cancer by the Combination of Rosiglitazone and Carboplatin. (2008) CLINICAL CANCER RESEARCH 1078-0432 1557-3265 14 20 p. 6478-6486
Richard C et al. Thiazolidinedione drugs down-regulate CXCR4 expression on human colorectal cancer cells in a peroxisome proliferator activated receptor gamma-dependent manner. (2007) INTERNATIONAL JOURNAL OF ONCOLOGY 1019-6439 1791-2423 30 5 p. 1215-1222
Brugos L et al. Modulation of adenosine-induced responses in the guinea-pig trachea during long-term caffeine treatment: Possible role of epithelium. (2007) JOURNAL OF PHARMACOLOGICAL SCIENCES 1347-8613 1347-8648 105 3 279-290,
1191358
Miko I et al. Spleen autotransplantation. Morphological and functional follow-up after spleen autotransplantation in mice: a research summary.. (2007) MICROSURGERY 0738-1085 1098-2752 27 4 312-316,
1115670
Figueiredo Jose-Luiz et al. A durable murine model of spleen transplantation with arterial and venous anastomoses. (2020) SCIENTIFIC REPORTS 2045-2322 10 1
Reza Javadi Mohammad et al. Histological Changes of Spleen Autotransplanted in the Omentum of Rats. (2019) JOURNAL OF ADVANCES IN MEDICINE AND MEDICAL RESEARCH 2456-8899 29 5
Soltani E et al. Which common test should be used to assess spleen autotransplant effect?. (2018) ULUSAL TRAVMA VE ACIL CERRAHI DERGISI-TURKISH JOURNAL OF TRAUMA & EMERGENCY SURGERY 1306-696X 1307-7945 24 1 16-19
Grunewald ST et al. Autotransplantation of spleen mitigates drug-induced liver damage in splenectomized mice. (2017) JOURNAL OF INVESTIGATIVE SURGERY 0894-1939 30 6 368-375
Chen S et al. Changes in nerve fibers and microvessel density in residual spleen after subtotal splenectomy due to portal hypertension. (2016) INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY 1936-2625 9 2 1557-1567
Hasanzadeh Ghavifekr et al. Evaluation of cellular changes of autotransplanted spleen tissue and serological changes in the peripheral blood of splenectomized and spleen autotransplanted rats. (2014) URMIA MEDICAL JOURNAL 25 10 940-953
